193 related articles for article (PubMed ID: 38599100)
21. Cancer vaccines in colon and rectal cancer over the last decade: lessons learned and future directions.
Berry J; Vreeland T; Trappey A; Hale D; Peace K; Tyler J; Walker A; Brown R; Herbert G; Yi F; Jackson D; Clifton G; Peoples GE
Expert Rev Clin Immunol; 2017 Mar; 13(3):235-245. PubMed ID: 27552944
[TBL] [Abstract][Full Text] [Related]
22. On the Verge: Immunotherapy for Colorectal Carcinoma.
Oh DY; Venook AP; Fong L
J Natl Compr Canc Netw; 2015 Aug; 13(8):970-8. PubMed ID: 26285242
[TBL] [Abstract][Full Text] [Related]
23. mRNA vaccine in cancer therapy: Current advance and future outlook.
Li Y; Wang M; Peng X; Yang Y; Chen Q; Liu J; She Q; Tan J; Lou C; Liao Z; Li X
Clin Transl Med; 2023 Aug; 13(8):e1384. PubMed ID: 37612832
[TBL] [Abstract][Full Text] [Related]
24. Clinical Application of Adaptive Immune Therapy in MSS Colorectal Cancer Patients.
Wang D; Zhang H; Xiang T; Wang G
Front Immunol; 2021; 12():762341. PubMed ID: 34721435
[TBL] [Abstract][Full Text] [Related]
25. Expanding the Scope of Immunotherapy in Colorectal Cancer: Current Clinical Approaches and Future Directions.
Kreidieh M; Mukherji D; Temraz S; Shamseddine A
Biomed Res Int; 2020; 2020():9037217. PubMed ID: 32090113
[TBL] [Abstract][Full Text] [Related]
26. Colorectal cancer vaccines: The current scenario and future prospects.
Jia W; Zhang T; Huang H; Feng H; Wang S; Guo Z; Luo Z; Ji X; Cheng X; Zhao R
Front Immunol; 2022; 13():942235. PubMed ID: 35990683
[TBL] [Abstract][Full Text] [Related]
27. Immunotherapy of colorectal cancer: new perspectives after a long path.
Correale P; Botta C; Ciliberto D; Pastina P; Ingargiola R; Zappavigna S; Tassone P; Pirtoli L; Caraglia M; Tagliaferri P
Immunotherapy; 2016 Nov; 8(11):1281-1292. PubMed ID: 27993089
[TBL] [Abstract][Full Text] [Related]
28. T-cell-based immunotherapy in colorectal cancer.
Feng M; Zhao Z; Yang M; Ji J; Zhu D
Cancer Lett; 2021 Feb; 498():201-209. PubMed ID: 33129958
[TBL] [Abstract][Full Text] [Related]
29. Colorectal cancer vaccines in clinical trials.
Speetjens FM; Zeestraten EC; Kuppen PJ; Melief CJ; van der Burg SH
Expert Rev Vaccines; 2011 Jun; 10(6):899-921. PubMed ID: 21692708
[TBL] [Abstract][Full Text] [Related]
30. Active specific immunotherapy for colorectal cancer.
Indar AA; Maxwell-Armstrong CA
Expert Rev Anticancer Ther; 2003 Oct; 3(5):685-94. PubMed ID: 14599091
[TBL] [Abstract][Full Text] [Related]
31. Immunotherapy of Colorectal Cancer.
Jäger D; Halama N; Zörnig I; Klug P; Krauss J; Haag GM
Oncol Res Treat; 2016; 39(6):346-50. PubMed ID: 27259331
[TBL] [Abstract][Full Text] [Related]
32. New strategies to improve the efficacy of colorectal cancer vaccines: from bench to bedside.
Mocellin S
Curr Opin Investig Drugs; 2006 Dec; 7(12):1052-61. PubMed ID: 17209522
[TBL] [Abstract][Full Text] [Related]
33. Combating colorectal cancer with immunotherapy: Where are we?
Gupta R; Bhatt LK; Prabhavalkar KS
Drugs Today (Barc); 2019 Aug; 55(8):513-528. PubMed ID: 31461088
[TBL] [Abstract][Full Text] [Related]
34. mRNA vaccines for cancer immunotherapy.
Vishweshwaraiah YL; Dokholyan NV
Front Immunol; 2022; 13():1029069. PubMed ID: 36591226
[TBL] [Abstract][Full Text] [Related]
35. Recognition of Tumor-Associated Antigens and Immune Subtypes in Glioma for mRNA Vaccine Development.
Ma S; Ba Y; Ji H; Wang F; Du J; Hu S
Front Immunol; 2021; 12():738435. PubMed ID: 34603319
[TBL] [Abstract][Full Text] [Related]
36. Colorectal cancer immunotherapy.
Xiang B; Snook AE; Magee MS; Waldman SA
Discov Med; 2013 May; 15(84):301-8. PubMed ID: 23725603
[TBL] [Abstract][Full Text] [Related]
37. Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacy.
Shebbo S; Binothman N; Darwaish M; Niaz HA; Abdulal RH; Borjac J; Hashem AM; Mahmoud AB
Front Immunol; 2024; 15():1350208. PubMed ID: 38533510
[TBL] [Abstract][Full Text] [Related]
38. Recent advances in active specific cancer vaccine treatment for colorectal cancer.
Okuno K; Sugiura F; Itoh K; Yoshida K; Tsunoda T; Nakamura Y
Curr Pharm Biotechnol; 2012 Jun; 13(8):1439-45. PubMed ID: 22339221
[TBL] [Abstract][Full Text] [Related]
39. Editorial: mRNA Vaccines and Immunotherapy in Oncology: A New Era for Personalized Medicine.
Parums DV
Med Sci Monit; 2021 May; 27():e933088. PubMed ID: 33994538
[TBL] [Abstract][Full Text] [Related]
40. Vaccines for colorectal cancer and renal cell carcinoma.
Kabaker K; Shell K; Kaufman HL
Cancer J; 2011; 17(5):283-93. PubMed ID: 21952277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
